MPIP: Melanoma Patients Information Page

The MPIP is the oldest and largest community of people affected by melanoma hosted through the Melanoma Research Foundation. It is designed to provide support and information to caregivers, patients, family and friends. Once you have been touched by melanoma—either as a patient or as a family member or friend of a patient—you become part of a community. It is not a community anyone joins willingly. But if you must be part of this group, you will find no better place to find the tools you need in your journey with this cancer, and the friends who can make that journey more bearable.

The information on the bulletin board is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Expand/ Collapse Topic
 
Replies By
View Topic
Leslie'sHusband's picture
Replies 6
Last reply 10/16/2014 - 8:53am
Replies by: Leslie'sHusband, Marianne quinn, Anonymous

Les had her CT scan at Duke two weeks ago.  She was supposed to get a PET/CT with contrast, but once again, insurance got in the way of what the doctors requested.  Anyway, they found a place on her liver, and a small spot on one of her lungs.  The doctors requested an MRI to take a closer look at the liver, but seem to not be excited about the lung.  We head back to Duke tomorrow for the MRI.  Here is what was written about the CT:

CT chest, abdomen, and pelvis with IV contrast

Comparison: Outside PET/CT dated 2/27/2014.

Indication: V10.82 Personal history of malignant melanoma of skin, eval
for metastases

Technique: CT imaging was performed of the chest, abdomen, and pelvis
following the uncomplicated administration of intravenous contrast
(Isovue-300, 150 mL at 3 mL/sec). Iodinated contrast was used due to the
indications for the examination, to improve disease detection and to
further define anatomy. The most recent serum creatinine is not available.
3-D maximal intensity projection (MIP) reconstructions of the chest were
performed to potentially increase study sensitivity. Coronal images were
also generated and reviewed.

Findings:
Chest:
There is a faint nodular opacity measuring 4 mm in the right lower lobe
(series 6, image 37). There is bibasilar atelectasis and scarring. There is
biapical pleural scarring.

The thyroid gland is normal in appearance. There is no evidence for
axillary, mediastinal, or hilar adenopathy. The heart is normal in size.
There is no pericardial effusion. The pulmonary parenchyma is normal in
appearance, with no abnormal pulmonary parenchymal opacities. There is no
pleural effusion. The central airways are patent.

Abdomen/Pelvis:
There is a enhancing lesion within the dome of the right hepatic lobe
measuring 1.7 x 1.3 cm (series 6, image 52). No additional hepatic lesions
are identified.. There is no intrahepatic or extrahepatic biliary
dilatation. The hepatic arteries, hepatic and portal veins are patent. The
gallbladder is normal. The adrenals, pancreas, and spleen are unremarkable
without evidence for focal lesion.

The kidneys enhance symmetrically. There is no pelvicaliectasis or
ureterectasis. There are no renal parenchymal lesions.

There are multiple loops of nondilated large and small bowel without
evidence for bowel obstruction or bowel wall thickening. There is no
abnormal mesenteric stranding. There is no mesenteric or retroperitoneal
lymphadenopathy. The urinary bladder is normal. There is no pelvic
lymphadenopathy.

There are no suspicious osseous lesions. There is a scoliotic curvature of
the thoracolumbar spine with degenerative changes.. There is a stable
sclerotic lesion in the left pubic ramus. There is a soft tissue density in
in the anterior left thigh measuring 2.5 x 1.4 cm, which is likely
postoperative (series 6, image 125).

Impression:
1. Hyperenhancing lesion within the dome of the right hepatic lobe, which
is indeterminant. Differential diagnosis includes both benign and malignant
pathology (benign: FNH, adenoma; malignant: metastatic melanoma). Further
is characterization with MRI is recommended.
2. Tiny right lower lobe pulmonary nodule.

 

We will be taking a print of this with us to ask questions as there are a couple of things mentioned that concern me that the doctors don't seem excited about.  I am going to do a little research into the medical terminology in the report this evening to try to put things in 'layman's terms' to try to understand better, and be able to ask intelligent questions. Hopefully the MRI will bring good news...

 

Login or register to post replies.

DMU's picture
Replies 0

I had surgery on 10/15/2014. Have stitches across entire lower back, took about an hour or so.  Surgeon said as long as biopsy and all other tests come back fine I will be ok.

Pain is not as bad as I thought it would be. I keep going from hot to very cold. Tired

Hope all this information I have posted helps others who may be scared and have them be able to see hope for a long and healthy future.

:)

Login or register to post replies.

JerryfromFauq's picture
Replies 1
Last reply 10/15/2014 - 9:13pm
Replies by: Happy_girl

My Wayne declared Victory over Melanoma through his faith in Jesus Christ at 7:46 am this morning ! He is with Jesus now .

 

I'm me, not a statistic. Praying to not be one for years yet.

Login or register to post replies.

jualonso's picture
Replies 11
Last reply 10/15/2014 - 4:29pm

Hi to everybody

Finally i have progression with Braf/Mek and we have decided to go through IPI.

Do i need washout period?

Some changes in diet?

Well, all advices are welcome....

Jualonso

Login or register to post replies.

Scientists have found 'breadcrumb trail' molecule that causes melanoma to spread

Apparently there’s a fatty molecule that irresistibly lures skin cancer cells around the body.

http://home.bt.com/news/sciencenews/scientists-have-found-breadcrumb-tra...

Scientific research has identified a type of fatty molecule that can make cancerous melanoma cells unusually aggressive and mobile, allowing it to spread round the body

The researchers have been looking at a fatty molecule known as lysophosphatidic acid (LPA).

Tests on lab cells and mice revealed how melanoma cells start their journey round the body by breaking down a nearby source of LPA.

Once they have depleted their original supply of the molecule, the skin cancer cells move out of their tumour in a bid to find more. They then move from molecule to molecule as if following a breadcrumb trail around the body.

I'm me, not a statistic. Praying to not be one for years yet.

Login or register to post replies.

Anonymous's picture
Anonymous
Replies 2
Last reply 10/15/2014 - 3:14pm
Replies by: JerryfromFauq

IF ANYONE IS AROUDN AND YOU WOULD LIKE TO COME TO CHAT A FEW OF US WILL BE THERE COME VISTI US.  WOULD LOVE TO MEET YOU.  LOOK FORWRD TO SEEING YOU.  

LOVE AND LIGHT

CAROLE K

Login or register to post replies.

Patina's picture
Replies 2
Last reply 10/15/2014 - 7:29am
Replies by: bilben_r, Ginger8888

Hi,

Are there any Yervoy responders who have gotten shingles?  If so, what happened after shingles? i.e. Did you stop responding to Yervoy, respond less or was this just a side effect?

My Mom had a shingles breakout (she has had them before) and there are not a lot of Yervoy patients who have had them.  Wondering if her immune system is under duress and Yervoy may not be working as well as it has, or what...  

Thanks!

Login or register to post replies.

BrianP's picture
Replies 4
Last reply 10/15/2014 - 4:21am
cbs805's picture
Replies 4
Last reply 10/15/2014 - 4:04am

Does anyone know what can be done about this? My husband has been required each time to sign an ABN (Advance Beneficiary Notice that the scans likely won't be covered by Medicare) for his PET/CT scans. Medicare has always paid until this last one. I know there is a limit to how many they will cover so apparently that limit has been met and we now have to pay. Is there a way of appealing this denial and getting it paid by Medicare? Why does Medicare limit the number of PET/CTs a patient can have? What scans do they recommend instead of the 6 month PET CT? Thank you

CBS805

Login or register to post replies.

Shollands's picture
Replies 8
Last reply 10/15/2014 - 2:46am

Hi Everyone

I have my first mole removal coming up and am very nervous!

 

i have been a regular sun bed user with fair skin that burns easily.

Has a new mole appear on my chest but wasn't worried as heard that it is common to develop new moles up till your 30's.

However, in the space of the last few weeks it has evolved, changed colour, got darker and is getting more raised by the day, nothing like any of my other moles.

am very scared at what the outcome may be. 

Any advice you can give would be really appreciated.

Thank you all

 

Login or register to post replies.

KerriM's picture
Replies 1
Last reply 10/14/2014 - 7:13pm
Replies by: Janner

After posting my story and reading others stories can anyone tell me why some patients have a lymph node biopsy at state IIa/b and some don't. I just had a WLE twice to remove it all....now I am nervous that maybe I should have had something else checked. When I was first diagnosed I went to a general surgeon for removal of the mole as I had two negative biopsies so when it came back I was surprised. I now see a surgeon who specialized in Melanoma (Just had three WLE last week). Now I am nervous after reading that maybe I should have had more testing?

 

Also - Does anyone else feel like they don't want to mention any small changes to their derm at their 6 month check ups because they have turned into a pin cushion? I can't believe I even feel this way and don't want to tell him about changes...am I nuts?

Login or register to post replies.

DMU's picture
Replies 5
Last reply 10/14/2014 - 3:14pm
Replies by: Squash, Girl52, washoegal, DMU, Janner

Met with my surgeon and he's very straight forward. He told me if I had waited any longer to see him and the melanoma was deeper, he would be telling me to gather my Family and get my things in order for I may not be here. 

Well, I'm glad to report that's not the case at this time. He set my surgery up for 2 days from now. Sent me to get liver blood work, chest  X-ray,, and a mammogram. Marked on my back where the surgery will be. Said he doesn't foresee any problems.

thanks for your help.  I'll keep you posted with updates.

Login or register to post replies.

Anonymous's picture
Anonymous
Replies 6
Last reply 10/14/2014 - 7:54am
Replies by: Anonymous, Carole K, Janner, JerryfromFauq

This is a little after the fact now, but should I be concerend that my melanoma was dx with a shave biopsy?   .86MM Thick.     I have been reading that this is not the best method when melanoma is suspected.   

DX as of now  Nevoid melanoma .86mm thick, Clarks level III, Mitioc rate of 3  No ulceration, Non Brisk

Both radical and vertical growth present 

Predominat Cytology:  Epitheloid

Thanks

g

Login or register to post replies.

FDA Approves Drug for Chemo-Associated Nausea, Vomiting

Mon, 10/13/2014

http://www.dddmag.com/news/2014/10/fda-approves-drug-chemo-associated-nausea-vomiting?et_cid=4205391&et_rid=657184103&location=top

elsinn Group and Eisai Inc. announced that the Food and Drug Administration (FDA) approved Akynzeo for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. Akynzeo is the first approved fixed combination oral agent that targets two critical signaling pathways associated with CINV by combining netupitant, an NK1 receptor antagonist, and palonosetron, a 5-HT3 receptor antagonist, in a single capsule for the prevention of CINV.

 
"Patients receiving chemotherapy face a significant burden due to CINV. Akynzeo may help alleviate part of that burden of chemotherapy by better managing nausea and vomiting up to five days following chemotherapy," said Paul Hesketh, M.D., Akynzeo pivotal study lead author and chair, Lahey Health Cancer Institute and director of Thoracic Oncology, Lahey Hospital & Medical Center. "The results from the pivotal trials show that Akynzeo provides superior prevention against nausea and vomiting compared with oral palonosetron.
As a result, physicians may be able to help patients manage CINV with a treatment that works both at the time of chemotherapy administration, and up to five days following treatment."
 
The approval of Akynzeo was based on the submission of Phase 2 and Phase 3 trials with Akynzeo in patients undergoing treatment with moderately and highly emetogenic chemotherapy regimens for a variety of tumor types. The most common adverse reactions reported with Akynzeo were headache, asthenia, fatigue, dyspepsia, constipation and erythema.
 
CINV is one of the most common side effects of chemotherapy. Its management has been refined over the past several decades, but despite the existence of effective treatments and clear antiemetic guidelines, many patients still suffer from CINV, particularly during the delayed phase after chemotherapy. Studies show that patients often receive antiemetic drug regimens that are inconsistent with CINV treatment guidelines, which call for multiple-pathway targeted antiemetic prophylaxis. Akynzeo provides cancer care teams with two antiemetics in a single oral fixed combination capsule. A combination of an NK1 receptor antagonist, a 5-HT3 receptor antagonist and dexamethasone meets guideline recommendations for optimal antiemetic therapy following highly emetogenic chemotherapy.
 
"Helsinn is delighted with the FDA approval of Akynzeo and we look forward to a successful launch in the United States. We are proud of our long-standing partnership with Eisai and Akynzeo is the newest development in our combined efforts," said Riccardo Braglia, Helsinn's Group chief executive officer. "This approval offers patients access to a new treatment option for CINV prevention that is effective in preventing both nausea and vomiting, particularly in the delayed phase, following emetogenic chemotherapy regimens."
 
"The approval of Akynzeo represents an important development in the prevention of acute and delayed nausea and vomiting for patients," said Yuji Matsue, chairman and chief executive officer, Eisai Inc. "We are proud to achieve this milestone with Akynzeo as we work to further our human health care mission to provide patients going through what we know can be emotionally- and physically-demanding cancer treatment with an additional option for CINV prevention."

 

I'm me, not a statistic. Praying to not be one for years yet.

Login or register to post replies.

Bulldogs81's picture
Replies 6
Last reply 10/13/2014 - 8:11pm

On 9/16 I had a mole on my forearm. On 9/24 my derm called and said it was melanoma in situ. She said that she sent it to the university of Chicago for a second opinion, who agreed it was in situ. She scheduled me for an appt for a wle the following Monday 9/29. I went, and the surgeon seemed to have taken a big chunk of my arm out. The scar is about 3 inches long and looks like skin is drooping inward.

 

Anyhow, a nurse from the surgeons office called today with the results. She said that the results came back today from wle and that it looks like they are going to have to a second excision. I was at the grocery store and caught off guard, because I was not expecting bad news and was so shocked that I did not ask a lot of questions. They wanted me to come in this week for second surgery, which is not possible for me so I go next monday. 

I called my derm so she could explain it to me and am waiting for a call back. I am so confused. Does this type of thing normally happen? Or does it mean the original diagnosis of in situ was incorrect? 

Login or register to post replies.

Pages